Eagle Health Investments’s uniQure QURE Stock Holding History

Eagle Health Investments’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-205,247	Closed	-$4.91M	–	35
2025 Q4	$4.91M	Buy	+205,247	New	+$7.92M	1.08%	22

Other funds holding QURE

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Eagle Health Investments's QURE Position: Q1 2026 in Review

Eagle Health Investments sold out of uniQure (QURE) in Q1 2026, closing a stake of 205,247 shares — an estimated $4.91M sold.

Eagle Health Investments first reported a position in QURE in Q4 2025 and held it in 1 quarter. The position peaked at $4.91M in Q4 2025. 213 funds tracked by Wall St. Rank hold QURE as of Q1 2026.

Eagle Health Investments reported no remaining uniQure position as of Q1 2026 after selling out during the quarter.
Eagle Health Investments sold 205,247 uniQure shares in Q1 2026, an estimated $4.91M.
Eagle Health Investments first reported a position in uniQure in Q4 2025 and held it in 1 quarter.
Eagle Health Investments's uniQure position peaked at $4.91M in Q4 2025.
213 funds tracked by Wall St. Rank held uniQure as of Q1 2026.

Based on Eagle Health Investments's 13F filing for Q1 2026, filed 15 May 2026.